Navigation Links
Petition to Ban Power Morcellator Surgery Now Has 62,800 Supporters, Bernstein Liebhard LLP Reports

New York, NY (PRWEB) August 15, 2014

More than 62,800 signatures are now included on a petition created by a Boston couple campaigning to end power morcellator ( ) surgery in the U.S., Bernstein Liebhard LLP reports.

As of August 15th, the petition had 62,927 supporters who similarly seek to ban use of the devices in laparoscopic hysterectomy and fibroid removal procedures. The campaign was spearheaded by the husband of a woman who was diagnosed with uterine leiomyosarcoma, a life-threatening form of uterine cancer, after having fibroids removed in October 2013. Since then, concerns surrounding the possible risk for uterine morcellation procedures to promote the spread of uterine cancer cells throughout the peritoneal cavity have continued to gain momentum in the U.S.

“We are pleased that more signatures have been added to this petition, as our Firm continues to hear from women whose uterine sarcoma and other cancers allegedly spread after power morcellator surgeries,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is actively investigating power morcellator lawsuits on behalf of women who may have received life-threatening cancer diagnoses after undergoing a uterine morcellation procedure.

Morcellator Lawsuits

The possible risks surrounding uterine morcellation have continued to gain media attention over the past several months, especially after the U.S. Food and Drug Administration (FDA) issued a public health alert in April that warned of the association between power morcellators and the spread of uterine sarcoma and other cancers. Among other things, the FDA alert estimated that 1 in every 350 women having fibroids removed may have undetected uterine sarcoma or another cancer prior to surgery, which may not be discovered until after fibroids are removed and biopsied.

Most recently, a study published in the Journal of the American Medical Association found that 1 in 368 women undergoing power morcellator surgeries may have undiagnosed uterine cancers. The research, which was released on July 22nd, 2014, also showed a higher likelihood of undetected cancer in women older than 65, and found that 32 percent of morcellation patients with the undiagnosed disease were younger than 50.*

On July 30th, Johnson & Johnson announced that it would be removing all power morcellators marketed by its subsidiary, Ethicon, Inc. from the market following its previous decision to cease sales of the devices. A notice posted on the company’s website indicated that its Gynecare Morcellex, Gynecare X-Tract and Morcellex Sigma morcellator systems would be withdrawn due to uncertain risks associated with their use.**

Women who may have been diagnosed with uterine cancer after power morcellator surgery may be eligible to file a lawsuit seeking compensation for damages allegedly caused by the device. To learn more about the possible risk between uterine morcellation and uterine sarcoma, please visit Bernstein Liebhard LLP’s website. To obtain a free legal review, please call 800-511-5092.

*, JAMA, July 22, 2014
**, Ethicon, Inc., July 30, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Casey Group's Sales Navigator Wins 2012 Best Mobility App in the New Jersey Technology Council's Mobile Application Competition
2. Clemson bioengineering team wins undergraduate design competition
3. New insights on cell competition
4. Managing care and competition
5. Kershaw, Cutter & Ratinoff Petitions FDA To Take Aggressive Action To Help People With Hip Replacement Problems
6. Amerejuve Dominates Houston's MedSpa Competition With Rapid Expansion: Houston's #1 MedSpa Opens Eighth Location in Kingwood
7. Aventura Rejuvenation Announces Their Biggest Loser 30 Day Weight Loss Competition
8. Knobbly knees in competition with fingerprints
9. The Human Brain Project: Winner of the of the largest European scientific funding competition
10. $5 million awarded in Sixth Starr Cancer Consortium Grant Competition
11. Mass. Eye and Ear researcher among winners of competition for Audacious ideas in research
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: